Featured Posts
On June 10, 2026, Broad Clinical Labs hosted a live webinar bringing together clinical and research leaders for an in-depth conversation on how Clinical Blended Genome-Exome Sequencing (cBGE) is reshaping...Read More
As a clinical and translational research service provider, our team at Broad Clinical Labs knows the integrity of your data is everything. You spend months, sometimes years, designing studies, recruiting...Read More
Cloud-native, scalable imputation from Broad Clinical Labs The All of Us + AnVIL Imputation Service helps researchers turn lower-cost genotype array data into richer datasets by filling in missing genetic...Read More
All of Us Research Program Biospecimen Access: An Opportunity to Transform Precision Medicine Through Multi-omics The NIH’s All of Us Research Program has spent 10 years assembling one of the most diverse and richly annotated...Read More
Nomic and Broad Clinical Labs partner to unlock broader applications for proteomics through high-plex, quantitative data that enables cross-study comparable insights. MONTREAL–(BUSINESS WIRE)–Nomic Bio today announced a partnership with...Read More
The National Multi-Omics Accelerator: How Broad Clinical Labs Provides Inclusive Access to Translational Science and Technology For three decades, the genomics field has refined the science and methodology of sequencing....Read More
From Bench to Clinical Scale: Broad Clinical Labs’ Approach to Scaling a Custom Assay Translating a high-performing custom benchtop assay into a reliable, clinical-grade operation at scale is technically challenging....Read More
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in...Read More
Short-Read vs. Long-Read WGS: Which is Right for Your Next Project? Key Takeaways: Your sequencing strategy decision impacts downstream analysis and research outcomes Short-read sequencing enables cost-efficient analysis of...Read More
At Broad Clinical Labs (BCL), the expertise behind our operations is powered by dedicated professionals who ensure that our science is accurate, reliable, and ready to make a real impact....Read More
On June 10, 2026, Broad Clinical Labs hosted a live webinar bringing together clinical and research leaders for an in-depth conversation on how Clinical Blended Genome-Exome Sequencing (cBGE) is...
All of Us Research Program Biospecimen Access: An Opportunity to Transform Precision Medicine Through Multi-omics The NIH’s All of Us Research Program has spent 10 years assembling one of...
Nomic and Broad Clinical Labs partner to unlock broader applications for proteomics through high-plex, quantitative data that enables cross-study comparable insights. MONTREAL–(BUSINESS WIRE)–Nomic Bio today announced a partnership...
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available...
Mass General Brigham Launches Genetic Test to Predict Risk Across Eight Cardiovascular Conditions Boston, MA – September 3,2025 — In a step forward for genomic-driven preventive medicine, Mass General...
In a pioneering collaboration aimed at transforming pediatric cancer diagnostics and research, Boston Children’s Hospital, Dana-Farber Cancer Institute, and Broad Clinical Labs have announced the formation of BrightSeq—Boston Research...